Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Yang

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|June 9, 2022
Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experienceSamantha J Seitter, Paul H McClelland, Mark A Ahlman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyRussell C Langan, Peter A Prieto, Richard M Sherry, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccineSteven A Rosenberg, James C Yang, Udai S Kammula, et al.
Annals of Surgical Oncology|September 18, 2016
Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced MelanomaNicholas D Klemen, Paul L Feingold, Stephanie L Goff, et al.
Journal for Immunotherapy of Cancer|September 27, 2023
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomicsCatherine M Ade, Matthew J Sporn, Sudipto Das, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2012
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanomaPeter A Prieto, James C Yang, Richard M Sherry, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinomaRichard E Royal, Catherine Levy, Keli Turner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2018
Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain MetastasesGautam U Mehta, Parisa Malekzadeh, Thomas Shelton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TILStephanie L Goff, Franz O Smith, Jacob A Klapper, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scansNanette M T Freedman, Senthil K Sundaram, Karen Kurdziel, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|June 9, 2022
Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experienceSamantha J Seitter, Paul H McClelland, Mark A Ahlman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyRussell C Langan, Peter A Prieto, Richard M Sherry, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 17, 2010
Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccineSteven A Rosenberg, James C Yang, Udai S Kammula, et al.
Annals of Surgical Oncology|September 18, 2016
Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced MelanomaNicholas D Klemen, Paul L Feingold, Stephanie L Goff, et al.
Journal for Immunotherapy of Cancer|September 27, 2023
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomicsCatherine M Ade, Matthew J Sporn, Sudipto Das, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2012
CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanomaPeter A Prieto, James C Yang, Richard M Sherry, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinomaRichard E Royal, Catherine Levy, Keli Turner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2018
Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain MetastasesGautam U Mehta, Parisa Malekzadeh, Thomas Shelton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TILStephanie L Goff, Franz O Smith, Jacob A Klapper, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scansNanette M T Freedman, Senthil K Sundaram, Karen Kurdziel, et al.
Pageof 16